CIK: 1277479 - Address: C/O Eyepoint Pharmaceuticals, Inc., 480 Pleasant Street, Watertown, MA 02472
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
6/25/24 16:16
6/23/24
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumAdamis Anthony PMADM.d00.00021004D
6/26/23 17:10
6/23/23
EYPTEyepoint Pharmaceuticals, Inc.DEElectrLabEqLaboratory Analytical InstrumAdamis Anthony PMADM.d00.0002New2D
11/7/05 17:43
11/3/05
EYETEyetech Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsAdamis Anthony PNYOChief ScM.d2841.360209999%225D
11/7/05 17:43
11/3/05
EYETEyetech Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsAdamis Anthony PNYOChief ScS.d-1,87617.680-106-32225D
8/1/05 17:07
8/1/05
EYETEyetech Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsAdamis Anthony PNYOChief ScS-6011.350-5-4123D
7/1/05 16:23
7/1/05
EYETEyetech Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsAdamis Anthony PNYOChief ScS-6712.590-5-4128D
6/3/05 16:15
6/1/05
EYETEyetech Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsAdamis Anthony PNYOChief ScS-6912.950-5-1241D
1/5/05 17:48
1/3/05
EYETEyetech Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsAdamis Anthony PNYOChief ScM.dm221.3601610632D
1/5/05 17:48
1/3/05
EYETEyetech Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsAdamis Anthony PNYOChief ScS.dm-72844.330-16-3432D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact